These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 9435251)

  • 1. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis.
    Hooper DC; Spitsin S; Kean RB; Champion JM; Dickson GM; Chaudhry I; Koprowski H
    Proc Natl Acad Sci U S A; 1998 Jan; 95(2):675-80. PubMed ID: 9435251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Uric acid as a scavenger in oxidative stress].
    Staub M
    Orv Hetil; 1999 Feb; 140(6):275-9. PubMed ID: 10071505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors.
    Scott GS; Spitsin SV; Kean RB; Mikheeva T; Koprowski H; Hooper DC
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16303-8. PubMed ID: 12451183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of mercaptoethylguanidine scavengers of peroxynitrite on the development of experimental allergic encephalomyelitis in PLSJL mice.
    Scott GS; Kean RB; Southan GJ; Szabó C; Hooper DC
    Neurosci Lett; 2001 Sep; 311(2):125-8. PubMed ID: 11567794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The peroxynitrite scavenger uric acid prevents inflammatory cell invasion into the central nervous system in experimental allergic encephalomyelitis through maintenance of blood-central nervous system barrier integrity.
    Kean RB; Spitsin SV; Mikheeva T; Scott GS; Hooper DC
    J Immunol; 2000 Dec; 165(11):6511-8. PubMed ID: 11086092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis.
    Hooper DC; Bagasra O; Marini JC; Zborek A; Ohnishi ST; Kean R; Champion JM; Sarker AB; Bobroski L; Farber JL; Akaike T; Maeda H; Koprowski H
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2528-33. PubMed ID: 9122229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis.
    Hooper DC; Scott GS; Zborek A; Mikheeva T; Kean RB; Koprowski H; Spitsin SV
    FASEB J; 2000 Apr; 14(5):691-8. PubMed ID: 10744626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of myelin basic protein immunized mice from free-radical mediated inflammatory cell invasion of the central nervous system by the natural peroxynitrite scavenger uric acid.
    Spitsin SV; Scott GS; Kean RB; Mikheeva T; Hooper DC
    Neurosci Lett; 2000 Oct; 292(2):137-41. PubMed ID: 10998568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Uric acid and multiple sclerosis].
    Mattle HP; Lienert C; Greeve I
    Ther Umsch; 2004 Sep; 61(9):553-5. PubMed ID: 15493114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uric acid in multiple sclerosis.
    Koch M; De Keyser J
    Neurol Res; 2006 Apr; 28(3):316-9. PubMed ID: 16687059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid.
    Squadrito GL; Cueto R; Splenser AE; Valavanidis A; Zhang H; Uppu RM; Pryor WA
    Arch Biochem Biophys; 2000 Apr; 376(2):333-7. PubMed ID: 10775420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of uric acid in protection against peroxynitrite-mediated pathology.
    Scott GS; Hooper DC
    Med Hypotheses; 2001 Jan; 56(1):95-100. PubMed ID: 11133262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum uric acid levels and leukocyte nitric oxide production in multiple sclerosis patients outside relapses.
    Mostert JP; Ramsaransing GS; Heersema DJ; Heerings M; Wilczak N; De Keyser J
    J Neurol Sci; 2005 Apr; 231(1-2):41-4. PubMed ID: 15792819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite.
    Koprowski H; Spitsin SV; Hooper DC
    Ann Neurol; 2001 Jan; 49(1):139. PubMed ID: 11198290
    [No Abstract]   [Full Text] [Related]  

  • 15. Cinnamon ameliorates experimental allergic encephalomyelitis in mice via regulatory T cells: implications for multiple sclerosis therapy.
    Mondal S; Pahan K
    PLoS One; 2015; 10(1):e0116566. PubMed ID: 25569428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of lysophosphatidic acids in multiple sclerosis and autoimmune encephalomyelitis.
    Schmitz K; Brunkhorst R; de Bruin N; Mayer CA; Häussler A; Ferreiros N; Schiffmann S; Parnham MJ; Tunaru S; Chun J; Offermanns S; Foerch C; Scholich K; Vogt J; Wicker S; Lötsch J; Geisslinger G; Tegeder I
    Acta Neuropathol Commun; 2017 Jun; 5(1):42. PubMed ID: 28578681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Agmatine Provides the New Insight in an Experimental Model of Multiple Sclerosis.
    Ninkovic M; Stevanovic I; Stojanovic I; Ljubisavljevic S; Basic J; Peric P
    Neurochem Res; 2015 Aug; 40(8):1719-27. PubMed ID: 26141226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum uric acid and multiple sclerosis.
    Rentzos M; Nikolaou C; Anagnostouli M; Rombos A; Tsakanikas K; Economou M; Dimitrakopoulos A; Karouli M; Vassilopoulos D
    Clin Neurol Neurosurg; 2006 Sep; 108(6):527-31. PubMed ID: 16202511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salutary effects of glibenclamide during the chronic phase of murine experimental autoimmune encephalomyelitis.
    Gerzanich V; Makar TK; Guda PR; Kwon MS; Stokum JA; Woo SK; Ivanova S; Ivanov A; Mehta RI; Morris AB; Bryan J; Bever CT; Simard JM
    J Neuroinflammation; 2017 Sep; 14(1):177. PubMed ID: 28865458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of nitric oxide synthase by arginase and methylated arginines during the acute phase of experimental multiple sclerosis.
    Ljubisavljevic S; Stojanovic I; Pavlovic R; Sokolovic D; Pavlovic D; Cvetkovic T; Stevanovic I
    J Neurol Sci; 2012 Jul; 318(1-2):106-11. PubMed ID: 22507752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.